Fast Money Video

  • Experimental Ebola drugs outlook  Wednesday, 8 Oct 2014 | 12:18 PM ET

    After the patient in Dallas died with the Ebola virus, the FMHR traders discuss how the event is impacting some of the stocks with experimental drugs.

  • Questions arise of Dallas Ebola patient's care  Wednesday, 8 Oct 2014 | 12:17 PM ET

    CNBC's Meg Tirrell reports the timeline of the Dallas patient who has died with the Ebola virus.

  • Supportive levels to watch  Wednesday, 8 Oct 2014 | 12:00 PM ET

    The FMHR traders dig into today's action, including small caps in a full blown correction.

  • Fast Money Final Trade  Tuesday, 7 Oct 2014 | 5:59 PM ET

    The "Fast Money" traders share their final trades of the day.

  • DJ: Valeant & Pershing to boost Allergan bid  Tuesday, 7 Oct 2014 | 5:58 PM ET

    Dow Jones is reporting citing sources that Valeant and Pershing Square plan to boost their bid for Allergan by around $15 per share. CNBC's Dominic Chu has the details.

  • Shale boom in 2030?  Tuesday, 7 Oct 2014 | 5:50 PM ET

    A new report says the shale boom will be even bigger than expected by 2030, and if the U.S. doesn't lift the oil export ban, prices could drop by $30. Harold York, Wood Mackenzie principal analyst, provides perspective.

  • Best buys on REITs  Tuesday, 7 Oct 2014 | 5:47 PM ET

    REITs outperformed the broader market in Tuesday's session. Jonathan Litt, Land and Buildings founder and CIO, shares his top two picks.

  • The "Fast Money" traders take a look at today's biggest market movers.

  • Earnings to watch: Costco, Alcoa & PepsiCo  Tuesday, 7 Oct 2014 | 5:35 PM ET

    CNBC's Dominic Chu reports on three stocks expected to report third quarter earnings this week.

  • The Ebola drug playbook  Tuesday, 7 Oct 2014 | 5:28 PM ET

    Companies with Ebola fighting drugs have been on the move recently. The "Fast Money" traders assess the risk in some of these investments.

  • The Ebola fighters  Tuesday, 7 Oct 2014 | 5:24 PM ET

    CNBC's Meg Tirrell reports how some drugs work to stop the Ebola virus from replicating, including Tekmira's TKM-Ebola and Chimerix's drug brincidofovir.

  • Top Trades: SodaStream selloff  Tuesday, 7 Oct 2014 | 5:18 PM ET

    The "Fast Money" traders run through a few stocks in focus today, including shares of SodaStream tanking after the company is said to be searching for a buyer.

  • Olive Garden turnaround to take time: Pro  Tuesday, 7 Oct 2014 | 5:14 PM ET

    Discussing Darden Restaurant's management on turning its brand Olive Garden around, with Rachael Rothman, Susquehanna Financial Group.

  • Yum's negative picture  Tuesday, 7 Oct 2014 | 5:14 PM ET

    Analyzing Yum! Brand's third quarter earnings miss, with Rachael Rothman, Susquehanna Financial Group.

  • GoPro falls on downgrade  Tuesday, 7 Oct 2014 | 5:07 PM ET

    Charlie Anderson, Dougherty & Co., has a neutral rating on GoPro's stock. Anderson says GoPro is a pure momentum stock, and an "eye of the beholder" type of stock.

  • Stocks sink; Where to look?  Tuesday, 7 Oct 2014 | 5:00 PM ET

    Dissecting the day's major business news, and the decline in stocks on growth concerns, with the "Fast Money" traders.

  • Fast Money Final Trade: C, CTRL, URI, FB  Tuesday, 22 Apr 2014 | 5:58 PM ET

    The Fast Money traders share their final trades of the day.

  • Xbox battles for your living room  Tuesday, 22 Apr 2014 | 5:48 PM ET

    Discussing Xbox series "Every Street United" and pricing competition for original content, with Jonathan Weinbach, Mandalay Sports Media executive producer and senior vice president.

  • Stock Pops & Drops: KORS, LXK, PHG, CONN  Tuesday, 22 Apr 2014 | 5:45 PM ET

    The Fast Money traders take a look at today's biggest market movers.

  • Biogen Idec has room to run: Pro  Tuesday, 22 Apr 2014 | 5:40 PM ET

    Mark Newton, Greywolf Execution Partners, looks at biotech's rebound and stabilization in the space.

Contact Fast Money Video

  • Showtimes

    Halftime Report - Weekdays 12p ET
    Fast Money - Weekdays 5p ET

Follow Fast Money Video